A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)

GSK Investigational Site, San Juan

GSK Investigational Site, New York

GSK Investigational Site, New York

GSK Investigational Site, New York

GSK Investigational Site, The Bronx

GSK Investigational Site, Manhasset

GSK Investigational Site, Philadelphia

GSK Investigational Site, Washington D.C.

GSK Investigational Site, Washington D.C.

GSK Investigational Site, Decatur

GSK Investigational Site, Pensacola

GSK Investigational Site, Orlando

GSK Investigational Site, Vero Beach

GSK Investigational Site, Miami

GSK Investigational Site, Fort Lauderdale

GSK Investigational Site, West Palm Beach

GSK Investigational Site, Sarasota

GSK Investigational Site, Ft. Pierce

GSK Investigational Site, Birmingham

GSK Investigational Site, Nashville

GSK Investigational Site, Cincinnati

GSK Investigational Site, Southfield

GSK Investigational Site, Watertown

GSK Investigational Site, Chicago

GSK Investigational Site, Columbia

GSK Investigational Site, Dallas

GSK Investigational Site, Houston

GSK Investigational Site, Houston

GSK Investigational Site, Austin

GSK Investigational Site, El Paso

GSK Investigational Site, Albuquerque

GSK Investigational Site, Santa Fe

GSK Investigational Site, Los Angeles

GSK Investigational Site, Los Angeles

GSK Investigational Site, Palm Springs

GSK Investigational Site, Bakersfield

GSK Investigational Site, San Francisco

GSK Investigational Site, Sacramento

GSK Investigational Site, Portland

GSK Investigational Site, New Haven

GSK Investigational Site, Boston

GSK Investigational Site, Springfield

GSK Investigational Site, Newark

GSK Investigational Site, Greensboro

GSK Investigational Site, San Juan